Figure 1From: Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical studyIndividual and mean changes in GIR at baseline and after 12 weeks of treatment with bezafibrate. ♦ = mean GIR; ● = individual GIR (n = 12). GIR = glucose infusion rate. *p < 0.05 vs. baseline (paired t test).Back to article page